Opiate-and cocaine-related fatal overdoses in Luxembourg from 1985 to 2011: A study on gender differences

European Addiction Research

Volumn 20, Issue 2, 2014, Pages 87-93

  Origer, Alain ^a   Lopes Da Costa, Sofia ^c   Baumann, Michèle ^b  

^a Ministry of Health   (Luxembourg)

^b UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^c LUXEMBOURG INSTITUTE OF HEALTH   (Luxembourg)

Author keywords

Drug use; Gender differences; Inequalities; Overdoses; Public health

Indexed keywords

COCAINE; ILLICIT DRUG; OPIATE; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT; AMPHETAMINE DERIVATIVE; CANNABIS; DIAMORPHINE; LYSERGIDE;

ADOLESCENT; ADULT; ARTICLE; DEATH; DRUG SURVEILLANCE PROGRAM; DRUG USE; EARLY INTERVENTION; FATAL OVERDOSE; FATALITY; FEMALE; FORENSIC IDENTIFICATION; HEALTH CARE PERSONNEL; HUMAN; INTOXICATION; LAW ENFORCEMENT; LUXEMBOURG; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PRIORITY JOURNAL; SEX DIFFERENCE; SOCIOECONOMICS; TIME OF DEATH; YOUNG ADULT; AUTOPSY; DRUG MISUSE; EDUCATIONAL STATUS; EMPLOYMENT; MULTIPLE DRUG ABUSE; PREMATURE MORTALITY; PUBLIC HEALTH; SOCIAL STATUS; SUBSTANCE ABUSE; UNEMPLOYMENT;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; DRUG OVERDOSE; FEMALE; HUMANS; LUXEMBOURG; MALE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POPULATION SURVEILLANCE; SEX CHARACTERISTICS; YOUNG ADULT;

EID: 84886741451     PISSN: 10226877     EISSN: 14219891     Source Type: Journal    
DOI: 10.1159/000355170     Document Type: Article

References (40)

1. UNODC: World Drug Report 2012. United Nations Publication. Vienna, UNODC, 2012.
2. WHO: Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks. Geneva, WHO, 2009.
3. EMCDDA: Mortality Related to Drug Use in Europe: Public Health Implications. Lisbon, European Monitoring Centre on Drugs and Drug Addiction, 2011.
4. Warner-Smith M, Darke S, Lynskey M, et al: Heroin overdose: causes and consequences. Addiction 2001; 96: 1113-1125. (Pubitemid 32738391)
5. Darke S, Kaye S, Duflou J: Systemic disease among cases of fatal opioid toxicity. Addiction 2006; 101: 1299-1305. (Pubitemid 44199521)
6. Green TC, McGowan SK, Yokell MA, et al: HIV infection and risk of overdose: a systematic review and meta-analysis. AIDS 2012; 26: 403-417.
7. Zador D, Sunjic S, Darke S: Heroin-related deaths in New South Wales, 1992: toxicological findings and circumstances. Med J Aust 1996; 164: 204-207. (Pubitemid 26057168)
8. Oppenheimer E, Tobutt C, Taylor C, et al: Death and survival in a cohort of heroin addicts from London clinics: a 22-year followup study. Addiction 1994; 89: 1299-1308. (Pubitemid 24310621)
9. Hickman M, Carrivick S, Paterson S, et al: London audit of drug-related overdose deaths: characteristics and typology, and implications for prevention and monitoring. Addiction 2007; 102: 317-323. (Pubitemid 46096294)
10. Jones R, Gruer L, Gilchrist G, et al: Recent contact with health and social services by drug misusers in Glasgow who died of a fatal overdose in 1999. Addiction 2002; 97: 1517-1522. (Pubitemid 36009107)
11. Darke S, Zador D: Fatal heroin 'overdose': a review. Addiction 1996; 91: 1765-1772.
12. Risser D, Bonsch A, Schneider B, et al: Drug fatalities from the forensic medicine viewpoint: 10 years' experiences of the Vienna Institute of Forensic Medicine (in German). Wien Klin Wochenschr 1994; 106: 677-680. (Pubitemid 24353890)
13. Ruttenber AJ, Luke JL: Heroin-related deaths: new epidemiologic insights. Science 1984; 226: 14-20. (Pubitemid 14035495)
14. Tunving K: Fatal outcome in drug addiction. Acta Psychiatr Scand 1988; 77: 551-566.
15. Harlow KC: Patterns of rates of mortality from narcotics and cocaine overdose in Texas, 1976-1987. Public Health Rep 1990; 105: 455-462.
16. Frischer M, Bloor M, Goldberg D, et al: Mortality among injecting drug users: a critical reappraisal. J Epidemiol Community Health 1993; 47: 59-63. (Pubitemid 23078251)
17. Bennett GA, Higgins DS: Accidental overdose among injecting drug users in Dorset, UK. Addiction 1999; 94: 1179-1189. (Pubitemid 29385146)
18. Hall W, Darke S: Trends in opiate overdose deaths in Australia 1979-1995. Drug Alcohol Depend 1998; 52: 71-77. (Pubitemid 28448705)
19. Hickman M, Madden P, Henry J, et al: Trends in drug overdose deaths in England and Wales 1993-98: methadone does not kill more people than heroin. Addiction 2003; 98: 419-425. (Pubitemid 36458125)
20. Bernstein KT, Bucciarelli A, Piper TM, et al: Cocaine-and opiate-related fatal overdose in New York City, 1990-2000. BMC Public Health 2007; 7: 31.
21. Degenhardt L, Bucello C, Mathers B, et al: Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011; 106: 32-51.
22. Antolini G, Pirani M, Morandi G, et al: Gender difference and mortality in a cohort of heroin users in the provinces of Modena and Ferrara, 1975-1999. Epidemiol Prev 2006; 30: 91-99.
23. Wagner FA, Anthony JC: Male-female differences in the risk of progression from first use to dependence upon cannabis, cocaine, and alcohol. Drug Alcohol Depend 2007; 86: 191-198. (Pubitemid 44821600)
24. Bargagli AM, Hickman M, Davoli M, et al: Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2006; 16: 198-202.
25. Lejckova P, Mravcik V: Mortality of drug users. Summary of cohort study results (in Czech). Epidemiol Mikrobiol Imunol 2005; 54: 154-160.
26. Torralba L, Brugal MT, Villalbi JR, et al: Mortality due to acute adverse drug reactions: opiates and cocaine in Barcelona, 1989-1993. Addiction 1996; 91: 419-426. (Pubitemid 26082859)
27. Bargagli AM, Sperati A, Davoli M, et al: Mortality among problem drug users in Rome: an 18-year follow-up study, 1980-1997. Addiction 2001; 96: 1455-1463. (Pubitemid 32977084)
28. Sanchez J, Rodriguez B, de la Fuente L, et al: Opiates or cocaine: mortality from acute reactions in six major Spanish cities. State Information System on Drug Abuse (SEIT) Working Group. J Epidemiol Community Health 1995; 49: 54-60.
29. Simoni-Wastila L, Ritter G, Strickler G: Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse 2004; 39: 1-23. (Pubitemid 38251904)
30. NIDA: Prescription Drugs: Abuse and addiction. NIH Publ. No. 01-4881. Rockville, US Department of Health and Human Services NIfH, National Insitute on Drug Abuse, 2001.
31. Conway KP, Compton W, Stinson FS, et al: Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2006; 67: 247-257. (Pubitemid 43357471)
32. Rounsaville BJ, Anton SF, Carroll K, et al: Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 1991; 48: 43-51.
33. Brooner RK, King VL, Kidorf M, et al: Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 1997; 54: 71-80. (Pubitemid 27044701)
34. Hernandez-Avila CA, Rounsaville BJ, Kranzler HR: Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment. Drug Alcohol Depend 2004; 74: 265-272. (Pubitemid 38759781)
35. Hser YI, Anglin MD, Booth MW: Sex differences in addict careers. 3. Addiction. Am J Drug Alcohol Abuse 1987; 13: 231-251.
36. Greenfield SF, Back SE, Lawson K, et al: Substance abuse in women. Psychiatr Clin North Am 2010; 33: 339-355.
37. Origer A: National Drug Report 2011: Statistical Buletin. Luxembourg, EMCDDA NFP Centre de Recherche Public-Sante, 2011.
38. Baumann M, Spitz E, Guillemin F, et al: Associations of social and material deprivation with tobacco, alcohol, and psychotropic drug use, and gender differentials. Int J Health Geogr 2007; 2: 50-60.
39. Anderson T: Neither Villain nor Victim: Empowerment and Agency among Women Substance Abusers. New Brunswick, Rutgers University Press, 2008.
40. EMCDDA: Treatment Demand Indicator (TDI). Standard Protocol 3.0: Guidelines for Reporting Data on People Entering Drug Treatment in European Countries. Lisbon, European Monitoring Centre on Drugs and Drug Addiction, 2006.